ST. LOUIS, Dec. 21, 2010 /PRNewswire/ -- Today, Pepex Biomedical, Inc. took delivery of bench prototypes and display models for their new nanotechnology-based Trio One-Click blood glucose meter. During the last year, a Phillips Plastics industrial design team, in close collaboration with Pepex engineers, designed and devolved bench prototypes and production level appearance models of the new Trio. These incorporate key requirements of the new meter concept and, of particular importance, represent what can be achieved using Pepex nanotechnology sensors. The result, of the companies' combined efforts, is the most convenient and advanced blood glucose monitoring system ever produced.
According to Pepex CEO, Steve Collins, "Phillips' exceptional cooperation with Pepex, producing our sensor module and the Trio bench prototypes and appearance models, clearly demonstrates Phillips' premier industrial design and manufacturing capabilities. We are extremely pleased to be working in concert to secure this partnership."
Both partners benefit from the agreement in a variety of ways. Phillips will profit from a product fit in their core business and the long-term business opportunity with the potential for product expansion. Pepex expects to continue to receive high quality products and enjoy substantial savings in development and speed to market.
Pepex' planned product line, the Trio One-Click family of blood glucose meters, incorporates the next generation in diabetes monitoring technology by: delivering greatly improved convenience, minimizing operator technique to reduce user errors, plus providing cost effective usage, to the estimated 285 million diabetics worldwide.
The Trio meter is a fully-integrated, single-point blood glucose monitoring system. The heart of the system is the Pepex CCM (Conductive Composite Monofilament) sensor nanotechnology. This patented nanotechnology is manufactured as a continuous monofilament, about t
|SOURCE Pepex Biomedical, Inc.|
Copyright©2010 PR Newswire.
All rights reserved